Amarin Corporation plc

NASDAQ:AMRN

Biotechnology

Healthcare
$11.26 +1.84%

+$0.29 today

Market cap
$232.89M
Beta
0.82
P/E (TTM)
-9.9
EPS (TTM)
-$1.62
52W Low $12.30High $20.90

Volume 0.09M

Average 0.07M

Income Statement

Follow revenue through to earnings.

Revenue

$213.65M

FY 2025 · Annual

-6.5% YoY

Operating Income

-$13.94M

FY 2025 · Annual

Net Income

-$38.80M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue583.19M369.19M306.91M228.61M213.65M
Cost of Revenue121.33M126.71M141.37M147.23M92.78M
Gross Profit461.86M242.48M165.54M81.38M120.87M
Gross Margin79.2%65.7%53.9%35.6%56.6%
Research & Development29.31M30.41M22.22M20.87M19.81M
Selling, General & Admin408.33M304.42M199.94M152.31M115M
Operating Expenses451.36M348.35M222.16M173.18M134.81M
Depreciation & Amortization2.86M3.1M2.97M3.01M3.03M
EBITDA14.28M(100.69M)(50.7M)(74.18M)(33.01M)
EBITDA Margin2.4%-27.3%-16.5%-32.4%-15.5%
Operating Income10.5M(105.87M)(56.62M)(91.8M)(13.94M)
Operating Margin1.8%-28.7%-18.4%-40.2%-6.5%
Interest Income1.22M2.82M11.86M13.4M10.85M
Interest Expense129K15K8K7K7K
Other Income / Expenses789K2.06M2.95M14.6M(22.11M)
Income Before Tax11.29M(103.81M)(53.67M)(77.2M)(36.05M)
Pre-Tax Margin1.9%-28.1%-17.5%-33.8%-16.9%
Income Tax Expense3.56M2M5.44M4.98M2.75M
Net Income7.73M(105.8M)(59.11M)(82.18M)(38.8M)
Net Margin1.3%-28.7%-19.3%-35.9%-18.2%
EPS (Basic)0.39(5.20)(3.00)(4.00)(1.80)
EPS (Diluted)0.38(5.20)(3.00)(4.00)(1.80)
Weighted Avg Shares19.8M20.06M19.7M20.55M20.75M
Weighted Avg Shares (Diluted)20.12M20.06M20.38M20.55M20.75M

AMRN Earnings Waterfall · TTM

NASDAQ:AMRN · Revenue to Net Income

Key Ratios

EPS$-1.62
Gross Margin50.2%
Net Margin-15.4%
P/E Ratio-20.9
P/S Ratio6.1

Analysis

$214.9M of revenue converted into -$33.6M of net income for the selected period. Gross margin is 50.2% and net margin is -15.4%, showing how much revenue survives after costs and taxes. EPS is $-1.62, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 28, 2026
10-QQuarterly reportOct 28, 2026
SC 13D/ASC 13D/A filingAug 27, 2026
4Statement of changes in beneficial ownershipAug 3, 2026
10-QQuarterly reportJul 29, 2026

How much revenue does AMRN generate?

Amarin Corporation plc (AMRN) reported $213.65M of revenue in fiscal 2025.

Is AMRN profitable?

Amarin Corporation plc (AMRN) reported -$38.80M of net income, with a net margin of -18.2%.